# The Study of Abatacept in Combination With Etanercept

> **NCT00162279** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 141 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Abatacept

## Key facts

- **NCT ID:** NCT00162279
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 141 (—)
- **Last updated:** 2010-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162279, "The Study of Abatacept in Combination With Etanercept". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00162279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*